|
Astex Pharma Ends Development of Lung Cancer Drug
Cancer drugmaker Astex Pharmaceuticals said it would discontinue the development of its experimental small-cell lung cancer drug, Amuvatinib, as the drug failed to achieve a high enough response rate in patients in a mid-stage study.
Reuters |
Register Now
Archives